Onconephrology: The intersections between the kidney and cancer
- PMID: 32853404
- DOI: 10.3322/caac.21636
Onconephrology: The intersections between the kidney and cancer
Abstract
Onconephrology is a new subspecialty of nephrology that recognizes the important intersections of kidney disease with cancer. This intersection takes many forms and includes drug-induced nephrotoxicity, electrolyte disorders, paraneoplastic glomerulonephritis, and the interactions of chronic kidney disease with cancer. Data clearly demonstrate that, when patients with cancer develop acute or chronic kidney disease, outcomes are inferior, and the promise of curative therapeutic regimens is lessened. This highlights the imperative for collaborative care between oncologists and nephrologists in recognizing and treating kidney disease in patients with cancer. In response to this need, specific training programs in onconephrology as well as dedicated onconephrology clinics have appeared. This comprehensive review covers many of the critical topics in onconephrology, with a focus on acute kidney injury, chronic kidney disease, drug-induced nephrotoxicity, kidney disease in stem cell transplantation, and electrolyte disorders in patients with cancer.
Keywords: acute kidney injury; chemotherapy; chronic kidney disease; electrolytes; glomerulonephritis; immunotherapy; kidney; myeloma; stem cell; transplantation.
© 2020 American Cancer Society.
Similar articles
-
Onconephrology: the need and the emergence of a subspecialty in nephrology.Kidney Int. 2014 May;85(5):1002-4. doi: 10.1038/ki.2014.29. Kidney Int. 2014. PMID: 24786870 No abstract available.
-
Onconephrology: the latest frontier in the war against kidney disease.J Am Soc Nephrol. 2013 Jan;24(1):26-30. doi: 10.1681/ASN.2012070690. Epub 2012 Nov 8. J Am Soc Nephrol. 2013. PMID: 23138480
-
Knowledge mapping and visualized analysis of research progress in onconephrology: a bibliometric analysis.Ren Fail. 2025 Dec;47(1):2477302. doi: 10.1080/0886022X.2025.2477302. Epub 2025 Mar 18. Ren Fail. 2025. PMID: 40101926 Free PMC article.
-
Onconephrology Fellowship Training: Current Status and Future Outlook.Kidney360. 2024 Sep 1;5(9):1380-1385. doi: 10.34067/KID.0000000000000495. Kidney360. 2024. PMID: 39325593 Free PMC article. Review.
-
Glomerular diseases and cancer: evaluation of underlying malignancy.J Nephrol. 2016 Apr;29(2):143-152. doi: 10.1007/s40620-015-0234-9. Epub 2015 Oct 26. J Nephrol. 2016. PMID: 26498294 Free PMC article. Review.
Cited by
-
The Impact of Chronic Kidney Disease on the Mortality Rates of Patients with Urological Cancers-An Analysis of a Uro-Oncology Database from Eastern Europe.J Pers Med. 2023 Nov 3;13(11):1572. doi: 10.3390/jpm13111572. J Pers Med. 2023. PMID: 38003887 Free PMC article.
-
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized 13C-labelled Z-OMPD.Nat Commun. 2023 Aug 21;14(1):5060. doi: 10.1038/s41467-023-40747-3. Nat Commun. 2023. PMID: 37604826 Free PMC article.
-
Is It Time to Integrate Frailty Assessment in Onconephrology?Cancers (Basel). 2023 Mar 8;15(6):1674. doi: 10.3390/cancers15061674. Cancers (Basel). 2023. PMID: 36980558 Free PMC article. Review.
-
Paraneoplastic renal dysfunction in fly cancer models driven by inflammatory activation of stem cells.bioRxiv [Preprint]. 2024 Mar 25:2024.03.21.586173. doi: 10.1101/2024.03.21.586173. bioRxiv. 2024. Update in: Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2405860121. doi: 10.1073/pnas.2405860121. PMID: 38585959 Free PMC article. Updated. Preprint.
-
Mendelian randomization study of the relationship between blood and urine biomarkers and lung cancer.Front Oncol. 2024 Dec 2;14:1453246. doi: 10.3389/fonc.2024.1453246. eCollection 2024. Front Oncol. 2024. PMID: 39687887 Free PMC article.
References
-
- Launay-Vacher V, Oudard S, Janus N, et al; Renal Insufficiency and Cancer Medications (IRMA) Study Group. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the Renal Insufficiency and Anticancer Medications (IRMA) study. Cancer. 2007;110:1376-1384.
-
- Launay-Vacher V. Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA Study Group. Semin Nephrol. 2010;30:548-556.
-
- Iff S, Craig JC, Turner R, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis. 2014;63:23-30.
-
- Launay-Vacher V, Janus N, Deray G. Renal insufficiency and cancer treatments. ESMO Open. 2016;1:e000091.
-
- Janus N, Launay-Vacher V, Byloos E, et al. Cancer and renal insufficiency: results of the BIRMA study. Br J Cancer. 2010;103:1815-1821.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical